Macrogenics (MGNX) Reports In-Line Q1 EPS

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.65), in-line with the analyst estimate of ($0.65). Revenue for the quarter came in at $13.19 million versus the consensus estimate of $14.06 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Reduce (3)
• Cerebras Q1 EPS miss sends shares down 9% after-hours